Author

Baiyang Fu

Institutions: Harbin Medical University, Second Affiliated Hospital of Harbin Medical University

Observed institutions: Harbin Medical University, Second Affiliated Hospital of Harbin Medical University

ORCID: 0000-0001-6704-3724

Observed ORCID: 0000-0001-6704-3724

OpenAlex ID: A5081840652

Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions

2023 · Hao Cui, Yue Sun, et al. · Journal of Translational Medicine · 50

Advances in micro-/nanorobots for cancer diagnosis and treatment: propulsion mechanisms, early detection, and cancer therapy

2025 · Baiyang Fu, Dan Luo, et al. · Frontiers in Chemistry · 14

Comparison of breast‐conserving surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A PSM and SEER database study

2023 · Baiyang Fu, Xi Chen, et al. · Cancer Medicine · 7

TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation

2026 · Xi Wang, Guangyan Li, et al. · Oncogene · 5

Inhibition of Lymphangiogenesis: A Protective Role of microRNA 146a‐5p in Breast Cancer

2024 · Wenlong Liang, Haoran Wang, et al. · The Breast Journal · 3

H3K27ac-induced IFITM3 promotes progression of TNBC and resistance to anti-PD-1/PD-L1 therapy via the TNF-α/NF-κB/PD-L1 axis

2026 · Guangyan Li, Baiyang Fu, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2

Clinically friendly smart hydrogel boosts cuproptosis and PD-L1 upregulation to enhance anti-tumor immunotherapy

2025 · Baiyang Fu, Guangyan Li, et al. · Materials Today Bio · 1

Inhibition of miR‐301a‐3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC

2026 · Baiyang Fu, Yuan Yao, et al. · The Breast Journal

Works count: 8

Citation count: 82

H-index: 4

I10-index: 2